Total Payments
$3,935
2024 Payments
$1,479
Companies
25
Transactions
166
Medicare Patients
11,172
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$3,745 (95.2%)
Education$190.01 (4.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,745 | 164 | 95.2% |
| Education | $190.01 | 2 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $550.54 | 15 | $0 (2024) |
| Janssen Biotech, Inc. | $495.69 | 20 | $0 (2024) |
| ABBVIE INC. | $442.78 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $419.36 | 21 | $0 (2024) |
| PFIZER INC. | $360.06 | 4 | $0 (2024) |
| LEO Pharma Inc. | $269.47 | 17 | $0 (2024) |
| Journey Medical Corporation | $214.74 | 2 | $0 (2023) |
| Arcutis Biotherapeutics, Inc. | $175.18 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $171.64 | 12 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $164.33 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,479 | 57 | Regeneron Healthcare Solutions, Inc. ($358.06) |
| 2023 | $1,467 | 67 | Janssen Biotech, Inc. ($371.43) |
| 2022 | $443.02 | 15 | PFIZER INC. ($104.71) |
| 2021 | $211.72 | 11 | AbbVie Inc. ($70.02) |
| 2020 | $249.99 | 9 | Regeneron Healthcare Solutions, Inc. ($52.89) |
| 2017 | $84.69 | 7 | CSL Behring ($24.06) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: DERMATOLOGY | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $43.98 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Dermatology | ||||||
| 11/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.07 | General |
| 10/11/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: Dermatology | ||||||
| 09/30/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.87 | General |
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Dermatology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: Dermatology | ||||||
| 09/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: IMMUNOLOGY | ||||||
| 08/26/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.54 | General |
| 08/22/2024 | Elekta, Inc. | ELEKTA MEDICAL LINEAR ACCELERATOR (Device) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: LINAC SOLUTIONS (LINAC) | ||||||
| 08/19/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $90.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 5,470 | 8,915 | $1.7M | $586,451 |
| 2022 | 31 | 3,464 | 5,143 | $779,997 | $350,730 |
| 2021 | 19 | 991 | 1,585 | $187,135 | $85,447 |
| 2020 | 14 | 1,247 | 1,728 | $120,930 | $54,214 |
Total Patients
11,172
Total Services
17,371
Medicare Billing
$1.1M
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 753 | 1,133 | $209,700 | $74,593 | 35.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 721 | 898 | $189,898 | $67,389 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 403 | 668 | $174,617 | $64,627 | 37.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 185 | 222 | $140,358 | $52,783 | 37.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 714 | 1,027 | $142,914 | $39,685 | 27.8% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 48 | 94 | $73,461 | $28,490 | 38.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 300 | 300 | $68,983 | $24,861 | 36.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 311 | 541 | $56,599 | $22,619 | 40.0% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 13 | 215 | $52,778 | $20,775 | 39.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 168 | 168 | $57,253 | $20,552 | 35.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 181 | 216 | $51,091 | $18,555 | 36.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 52 | 59 | $38,791 | $15,415 | 39.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 129 | 147 | $38,528 | $14,587 | 37.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 63 | 93 | $34,527 | $11,170 | 32.4% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 42 | 45 | $29,004 | $11,142 | 38.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 446 | 1,997 | $27,710 | $10,910 | 39.4% |
| 96573 | Application of light by qualified health care professional to destroy precancer skin growth | Office | 2023 | 27 | 54 | $25,894 | $9,556 | 36.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 186 | 208 | $24,153 | $9,231 | 38.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 66 | 75 | $38,088 | $7,648 | 20.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 57 | 64 | $37,083 | $7,439 | 20.1% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 20 | 32 | $18,741 | $7,347 | 39.2% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 51 | 56 | $31,108 | $6,245 | 20.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 111 | 111 | $16,486 | $5,131 | 31.1% |
| 69100 | Biopsy of ear | Office | 2023 | 63 | 76 | $15,267 | $4,317 | 28.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 27 | 30 | $10,524 | $4,032 | 38.3% |
About Dr. Patrick Brown, M.D
Dr. Patrick Brown, M.D is a Dermatology healthcare provider based in Cumberland, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2009. The National Provider Identifier (NPI) number assigned to this provider is 1689801789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Brown, M.D has received a total of $3,935 in payments from pharmaceutical and medical device companies, with $1,479 received in 2024. These payments were reported across 166 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,745).
As a Medicare-enrolled provider, Brown has provided services to 11,172 Medicare beneficiaries, totaling 17,371 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology, Dermatology
- Location Cumberland, MD
- Active Since 06/16/2009
- Last Updated 03/07/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1689801789
Products in Payments
- DUPIXENT (Biological) $568.90
- TREMFYA (Drug) $495.69
- COSENTYX (Drug) $318.58
- SKYRIZI (Biological) $306.59
- ADBRY (Biological) $269.47
- Sotyktu (Drug) $171.64
- CIBINQO (Drug) $157.36
- Bimzelx (Biological) $156.74
- Zoryve (Drug) $116.79
- COSENTYX (Biological) $100.78
- LITFULO (Drug) $97.99
- Otezla (Drug) $76.50
- HUMIRA (Biological) $69.70
- XTRAC (Device) $63.06
- AKLIEF (Drug) $59.79
- OPZELURA (Drug) $59.52
- RINVOQ (Biological) $54.18
- BLU-U (Medical Supply) $53.93
- ILUMYA (Biological) $50.07
- Odomzo (Drug) $40.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.